XML 47 R34.htm IDEA: XBRL DOCUMENT v3.23.2
FAIR VALUE MEASUREMENTS (Narrative) (Details)
$ in Millions
6 Months Ended
Jun. 30, 2023
USD ($)
Jun. 20, 2023
USD ($)
Dec. 31, 2022
USD ($)
Jul. 01, 2015
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Fair value of debt $ 4,000   $ 3,700  
UMass Joint Venture        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Ownership percentage by noncontrolling owners       18.90%
Fair Value, Inputs, Level 3 | Contingent Consideration        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Liability 93   $ 23  
Fair Value, Inputs, Level 3 | Contingent Consideration | Other Liabilities        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Liability 88      
Fair Value, Inputs, Level 3 | Contingent Consideration | Accounts Payable and Accrued Expenses        
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]        
Liability $ 5      
Haystack Oncology, Inc.        
Business Acquisition [Line Items]        
Contingent consideration   $ 88    
Haystack Oncology, Inc. | Comparable Company Revenue Volatility        
Business Acquisition [Line Items]        
Measurement input 0.40      
Haystack Oncology, Inc. | Discount rate        
Business Acquisition [Line Items]        
Measurement input 0.105      
Haystack Oncology, Inc. | Additional, Based on Revenue        
Business Acquisition [Line Items]        
Maximum contingent consideration payment   100    
Haystack Oncology, Inc. | Additional, Reimbursement Coverage        
Business Acquisition [Line Items]        
Maximum contingent consideration payment   50    
Haystack Oncology, Inc. | Additional Impact        
Business Acquisition [Line Items]        
Impact of market discount rate on contingent consideration obligation $ 21      
Contingent consideration   $ 88    
Haystack Oncology, Inc. | Additional Impact | Discount rate        
Business Acquisition [Line Items]        
Measurement input 0.05      
Haystack Oncology, Inc. | Changing Comparable Company Revenue Volatility | Comparable Company Revenue Volatility        
Business Acquisition [Line Items]        
Measurement input 0.30      
Increase in contingent consideration liability $ 7      
Haystack Oncology, Inc. | Changing Discount Rate | Comparable Company Revenue Volatility        
Business Acquisition [Line Items]        
Increase in contingent consideration liability $ 5      
Haystack Oncology, Inc. | Changing Discount Rate | Discount rate        
Business Acquisition [Line Items]        
Measurement input 0.070